Posts Tagged ‘Drug companies’

Manufacturing Depression—Are Docs Over Prescribing Antidepressants to a Tune of $10 Billion a Year for Drug Companies?

Wednesday, March 3rd, 2010

AlterNet
By Amy Goodman
March 3, 2010

A psychotherapist says depression can be debilitating — but that it’s also been largely created by doctors and drug companies as a medical condition.

Is depression manufactured? Two decades after the introduction of antidepressants, it’s become commonplace to assume that our sadness can be explained in terms of a disease called depression. The National Institute of Mental Health estimates more than 14 million Americans suffer from major depression every year and more than three million suffer from minor depression. Some 30 million Americans take antidepressants at a cost of over $10 billion a year.

My next guest argues while depression can be debilitating, it’s also been largely manufactured by doctors and drug companies as a medical condition with a biological cause that can be treated with prescription medication. Psychotherapist and writer Gary Greenberg participated in a clinical trial for antidepressant medication and found that more often than not the drugs failed to outperform placebos. His latest book is a scientific, medical, historical and cultural exploration of the antidepressant revolution here in the United States. It’s called Manufacturing Depression: The Secret History of a Modern Disease.

Read entire article:  http://www.alternet.org/health/145850/%27manufacturing_depression%27:_are_doctors_over-prescribing_antidepressants_to_a_tune_of_$10_billion_a_year_for_drug_companies/

« Return to news items


  • Share/Bookmark

The Emperor’s New Drugs: Exploding the Antidepressant Myth—Debunking the Chemical Imbalance Theory & Drug Efficacy

Wednesday, February 24th, 2010

PopMatters
By Chris Barsanti
February 24, 2010

What if antidepressants were not just too easily available and overly prescribed by doctors—as has been argued in many venues for years now, though to no discernible effect—but didn’t even work? That’s the takeaway premise of psychology professor Irving Kirsch, Ph.D., in his new book, The Emperor’s New Drugs: Exploding the Antidepressant Myth.

By examining a broad spectrum of research, using both the published drug studies and the deep well of unpublished research which many drug companies would prefer stay hidden, Kirsch presents the all-too-plausible theory that there is essentially no positive effect from taking antidepressants. In fact, comparing test results between patients taking antidepressants and those taking active placebos (a drug that isn’t an antidepressant but has other, noticeable side effects, so that the patient can tell something is working on them), Kirsch found no statistically significant difference. Actually, he found that it didn’t seem to matter what drug patients were taking, as long as they knew they had ingested some kind of active drug, they improved by about the same degree. So much for the last few decades’ great advances in pharmacology, it would seem.

If what Kirsch is saying is true, then not only are untold millions being wasted on essentially worthless drugs, but an entire school of psychological thought is utterly wrong. Kirsch spends an entire chapter of his tightly argued book tearing down the oft-recited belief that depression is frequently or always caused by a chemical imbalance in the brain. After relating several studies which purport to show that drugs which increase, decrease, or have no effect on the serotonin levels in patients brains (something long described as crucial to pharmacological therapy) all have about the same effect, Kirsch concludes very simply that “the data just do not fit the theory”.

Read entire article:  http://www.popmatters.com/pm/post/121266-the-emperors-new-drugs-exploding-the-antidepressant-myth/

« Return to news items


  • Share/Bookmark

Psychiatry completes their mission to pathologize every single human behavior into a mental disorder with new DSM

Saturday, February 13th, 2010

The Sunday Times
By Lois Rogers
February 14, 2010

Psychiatrists are to give official recognition to dozens of new mental disorders, including a condition nicknamed “Mary Whitehouse syndrome” — the thrill of being appalled by pornography and other obscenities.

Absexuality appears to have been inspired by the zeal of Whitehouse, the campaigner who railed against smut on television.

The condition is one of many mood disorders and personality traits that are likely to be added to the next edition of the psychiatrists’ “bible”.

The disorders, which also include hypersexuality — the desire for multiple partners, perhaps characterised by the golfer Tiger Woods — reflect changing social patterns.

However, critics believe their classification as psychiatric problems may lead them to be exploited for profit by drug companies.

Other new conditions include sluggish cognitive tempo disorder, which some would regard as simple laziness, and relational disorder, in which two people — often a separating couple — struggle to get on.

People who whinge constantly may be suffering negativistic personality disorder. Intermittent explosive disorder — otherwise known as adult tantrums — is also defined for the first time.

The conditions are named in a draft version of the Diagnostic and Statistical Manual of Mental Disorders , a key reference book for psychiatrists for more than 50 years.

Read entire article:  http://www.timesonline.co.uk/tol/life_and_style/health/article7026324.ece

« Return to news items


  • Share/Bookmark

Renowned Psycho/Pharma whistleblower Allen Jones speaks out on risks & vindication

Monday, February 1st, 2010

WHYY News and Information
By Kerry Grens
February 1, 2010

Last year, several federal juries in Philadelphia returned the largest ever settlements against drug companies. These lawsuits, which resulted in billions in fines, were spurred by a handful of whistleblowers. WHYY’s Kerry Grens looks at the growing phenomenon of the whistleblower suit.

Allen Jones comes across as …. intense. He lives in a cabin he built in the woods of Snyder County Pennsylvania. He speaks in a very direct and exacting manner. He smokes, and runs his hand through his hair when he gets lost in his thoughts.

Eight years ago, Jones worked as an investigator in Pennsylvania’s Office of the Inspector General.

Jones: An issue landed on my desk involving the state pharmacist Stephen Fiorello.

Jones was asked to look into payments Fiorello had received from pharmaceutical companies. To Jones, it seemed obvious. The payments involved a conflict of interest verging on crime.

Jones: As all of this began to emerge, I began to press my supervisor to broaden the investigation from a personnel issue into a fraud issue and to look more closely at what the drug companies were doing.

Read entire article:  http://whyy.org/cms/news/health-science/2010/02/01/why-people-blow-the-whistle-and-what-they-get-out-of-it/29471

« Return to news items


  • Share/Bookmark

Depression as a mass marketing campaign: Drug companies profit as antidepressant prescriptions increase

Friday, November 27th, 2009

Keith McLaughlin
The Argosy.ca
November 26, 2009

Since the emergence of antidepressant drugs in the early 1980s, more and more cases of depression are being reported. According to Dr. Brad Hagen, a clinical psychologist and faculty member at the University of Lethbridge, the reason for the skyrocketing rates of depression are a matter of heated debate.
“Depending on how you look at it, depression either started becoming more common or recognized, or it became marketed,” says Hagen.
In the 1950s, reported cases of depression were practically unheard of, but now the World Health Organization warns it could become the second leading cause of disability in the world by 2020.
Most persons with depression are treated by antidepressants, even though counseling – which can be significantly more expensive and time-consuming – has demonstrated equal effectiveness in offsetting feelings of depression. In the U.S, 87 per cent of physician visits for depression result in antidepressants being prescribed.
In 2007, sales of antidepressants topped $11.9 billion in the U.S.
Some in the medical community wonder if the spike in diagnosed depression cases over the last twenty years is exaggerated.
“Some question whether it’s an overinflated number because essentially there’s people that benefit from so many people being diagnosed,” says Hagen.

Read entire article: http://www.argosy.ca/view.php?aid=41974

« Return to news items


  • Share/Bookmark

Sen. Grassley’s bill requires disclosure of Pharma $ to doctors, ghost writers & “patient advocacy” groups like NAMI

Friday, October 23rd, 2009

IowaPolitics.com
October 23, 2009

WASHINGTON — Senator Chuck Grassley is continuing his campaign to establish transparency with the financial relationships between drug companies and medical professionals.

Grassley has conducted oversight and sought disclosure with physicians, especially those involved in influential taxpayer-sponsored medical research; medical journals containing ghostwritten articles; medical colleges; continuing medical education; and the patient advocacy community.

This week, the senator released a letter seeking information from state-level chapters of the National Alliance on Mental Illness. The inquiry follows one Grassley made earlier this year asking NAMI and other patient advocacy groups and medical professional societies for information about financial relationships with drug companies and medical device manufacturers. The letter is posted with this news release at http://grassley.senate.gov and http://finance.senate.gov.

“Public trust and public dollars are at stake,” Grassley said. “People rely on medical advice and taxpayers spend billions of dollars on prescription drugs and devices through Medicare and Medicaid. Public confidence could be greatly improved if financial relationships were disclosed. My legislative effort is a common-sense reform that would require the pharmaceutical and device industry to report the money it gives to doctors.”

Read entire article: http://www.iowapolitics.com/index.iml?Article=174518

« Return to news items


  • Share/Bookmark

How Pharma Can Skew Drug Trial Results: If patients taking a drug die, study may include only those that survived

Tuesday, September 29th, 2009

Tom Spears
CanWest News Service
September 29, 2009

OTTAWA – Doctors and patients may not get the full story on some prescription drugs because companies sidestep rules and hide test results, according to researchers in Canada, France and Britain.

Anyone doing a clinical trial of a drug is supposed to announce publicly that the trial is under way and describe its goals. But David Moher of the Ottawa Hospital Research Institute said many tests are conducted without this disclosure.

This allows scientists, or the drug companies who pay for the work, to release good results but quietly cancel anything that looks bad for their product.

“Selective outcome [result] reporting is prevalent,” Dr. Moher’s study concluded.

Read entire article: http://www.ottawacitizen.com/health/Drug+firms+hiding+test+results+Study/2042678/story.html

« Return to news items


  • Share/Bookmark

Shrinks for sale: Psychiatrist makes $22,500 in 3 months doing “educational” drug speeches for Eli Lilly

Monday, September 21st, 2009

Bob LaMendola
South Florida Sun-Sentinel
September 19, 2009

Boca Raton psychiatrist Donna Holland spent a day this month in San Antonio talking to doctors about the hyperactivity drug Strattera for manufacturer Eli Lilly and Co.

Her pay for that 45-minute speech: $1,500 plus expenses.

She’s one of 24 doctors in Broward and Palm Beach counties who were paid a total of $200,000 in speaking fees from Lilly in the first three months of 2009. Payments made to 3,400 doctors nationwide were disclosed as part of a settlement with the federal government over the company’s illegal marketing practices.

The list casts a spotlight on a widespread, legal but controversial practice of drug and medical companies paying doctors to give speeches about products to other doctors. Critics, including health experts, members of Congress and some doctors, say the speakers may change the drugs they prescribe based on who’s paying them, and the doctors in the audience are exposed to a sales pitch disguised as teaching.

Read entire article: http://www.sun-sentinel.com/sfl-doctor-drugmoney-092009,0,2156852.story

« Return to news items


  • Share/Bookmark

Pharma spends billions marketing to doctors; Eli Lilly paid $22 million in first 3 months of the year

Friday, August 28th, 2009

Kris Hundley
St. Petersburg Times
August 30, 2009

There are lots of reasons why your doctor might switch your prescription to a Lilly drug.

One of them might be found in a new online database that lists how much Eli Lilly & Co. paid physicians for their expertise during the first quarter of 2009.

For the first time, Floridians can see if their doctors juggled patient appointments with speaking gigs for the maker of popular drugs like Cymbalta, Zyprexa and Cialis.

Drug companies spend billions on marketing to doctors because it works: Targeted doctors prescribe more of the company’s products.

Lilly was forced to disclose its physician pay data, which it calls a “faculty registry,” as part of a $1.4-billion settlement with the federal government earlier this year.

Read entire article: http://www.tampabay.com/news/health/medicine/drug-makers-willing-to-pay-to-get-doctors-approval/1031817

« Return to news items


  • Share/Bookmark

The Mothers Act: Disease Mongering Campaign – Part IV by Evelyn Pringle

Thursday, August 27th, 2009

Evelyn Pringle
Natural News
August 26, 2009

The Mothers Act campaign has evolved into the most rabid gang of disease mongers seen in recent years, likely due to its 8-year existence.

In the 2002 paper titled, “Selling sickness: the pharmaceutical industry and disease mongering,” in the British Medical Journal, Ray Moynihan, Iona Heath, and David Henry, describe the mechanisms of the Mothers Act disease mongering campaign to a tee when explaining that:

“Within many disease categories informal alliances have emerged, comprising drug company staff, doctors, and consumer groups. Ostensibly engaged in raising public awareness about underdiagnosed and undertreated problems, these alliances tend to promote a view of their particular condition as widespread, serious, and treatable.”

“A key strategy of the alliances is to target the news media with stories designed to create fears about the condition or disease and draw attention to the latest treatment. Company sponsored advisory boards supply the “independent experts” for these stories, consumer groups provide the “victims,” and public relations companies provide media outlets with the positive spin about the latest “breakthrough” medication.”

The A Team

In review, the main leaders of the Mothers Act disease mongering campaign include Susan Dowd Stone and Karen Kleiman, two social workers who own treatment centers recruiting customers via their websites, PerinatalPro and Postpartum Stress Center, and who also sell books. The two most prominent “victims” or “human faces” in the campaign are Katherine Stone with the “Postpartum Progress,” website and Lauren Hale with a site called “Sharing the Journey.”

All the websites follow the lead of a group called, “Pospartum Support International,” and parrot the buzz words and phrases invented by the self-interested specialists and experts, such as “women’s reproductive mental health,” and “pregnancy related mood disorders,” and “reproductive psychiatry.”

Read entire article:  http://www.naturalnews.com/026926_depression_disease_health.html

« Return to news items


  • Share/Bookmark